ZTS - Zoetis Inc

https://www.zoetis.com

Buy Momentum: Bearish

Recent News

Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain

Zacks Commentary • 1 hour, 53 minutes ago • score: 0.47

ZTS secures CVMP's positive opinion recommending the approval of Portela, a long-acting OA pain therapy for cats, with final decision expected in late 2025.

Bullish

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Zacks Commentary • 3 days ago • score: 0.56

Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR ( SDZNY Quick QuoteSDZNY - ) or Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...

Bullish

Zoetis ( ZTS ) Stock Sinks As Market Gains: Here's Why

Zacks Commentary • 5 days, 17 hours ago • score: 0.30

Zoetis (ZTS) reached $149.79 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.

Bullish

If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now

Zacks Commentary • 2 weeks, 3 days ago • score: 0.32

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Bullish

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zacks Commentary • 2 weeks, 5 days ago • score: 0.50

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-09 (Snapshot)

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

52W High

$197.91

52W Low

$138.76

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.89

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

26.39

Forward P/E (<15 better)

22.73

EV/EBITDA (<8 favorable)

18.24

EV/Revenue (<3 favorable)

7.81

P/S (TTM) (<3 favorable)

7.24

P/B (<3 favorable)

13.65

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.09%

Institutions (25–75% balanced)

98.60%

Shares Outstanding

443,183,000

Float

442,315,000

Dividend Yield (2–6% sweet spot)

0.01%

Ex‑Dividend Date

2025-07-18

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

9,385,000,000

Gross Profit (TTM)

6,707,000,000

EPS (TTM)

5.81

Profit Margin (>10% good)

0.28%

Operating Margin (TTM) (higher better)

0.40%

ROE (TTM) (>15% strong)

0.53%

EPS YoY (Quarterly) (>10% good)

0.18

Revenue YoY (Quarterly) (>8% good)

0.04

Momentum

Bearish momentum

Value

-0.2450

0.1629

Trend

Falling

Signal Cross

No cross

As of

Sep. 09, 2025